Nashville-headquartered Thyme Care recently secured $60 million in funding to expand its health services for cancer patients, including palliative care and programs to address social determinants.
The value-based oncology provider has a team of nurses and care professionals that support roughly 3,000 patients and families navigating cancer and serious illness.
The funding round will allow Thyme Care to deepen its partnerships with health care providers across the continuum and widen its geographic reach, according to Dr. Samyukta Mullangi, the company’s medical director.
“What we hope that we use this capital for is wanting stakeholders to really feel that much more [people] are supported by us partnering in their journey,” Mullangi told Palliative Care News. “Patients really should feel a much more seamless cancer care experience than their counterparts who don’t have this access. Care teams should feel confident in their care plans and have somebody to call if a need arises so that they secure better health outcomes as a result.”